Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A Population-Based Study of Sociodemographic and Geographic Variation in HPV Vaccination.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Philadelphia, PA : American Association for Cancer Research, c1991-
    • الموضوع:
      Socioeconomic Factors*; Demography/*statistics & numerical data ; Papillomavirus Infections/*prevention & control ; Papillomavirus Vaccines/*administration & dosage ; Vaccination/*statistics & numerical data; Adolescent ; Age Factors ; Behavioral Risk Factor Surveillance System ; Child ; Female ; Humans ; Logistic Models ; Male ; Minnesota ; Sex Factors
    • نبذة مختصرة :
      Background: Human papillomavirus (HPV) vaccination rates in the United States remain low and lag behind other recommended adolescent vaccines. Studies evaluating the association of geographic and area-level characteristics with HPV vaccination rates provide a valuable resource for public health planning. Method: We used the Rochester Epidemiology Project data linkage system to ascertain HPV vaccination rates between 2010 and 2015 in a 7-county region of southern Minnesota. Geocoded individual patient data were spatially linked to socioeconomic data from the American Community Survey at the census block group level. Bayesian hierarchical logistic regression was used to model incident vaccination rates, adjusting for individual- and area-level sociodemographic characteristics, and geolocation. Geolocation was modeled as an approximated Gaussian field using a Stochastic Partial Differential Equations approach. All models were estimated using Integrated Nested Laplace Approximations. Results: In adjusted models, increasing age and female sex were associated with increased HPV vaccination. Lower socioeconomic status was associated with decreased rates of initiation [adjusted odds ratio (AOR); 95% confidence interval = 0.90 (0.86-0.95)], completion of the second dose [AOR = 0.88 (0.83-0.93)], and completion of the third dose [AOR = 0.85 (0.80-0.92)]. Geographic spatial analysis demonstrated increased odds of vaccination for the eastern region and in the greater Rochester metropolitan area, showing significant spatial variation not explained by individual level characteristics and ACS block group-level data. Conclusions: HPV vaccination rates varied geographically and by individual and geographically indexed sociodemographic characteristics. Impact: Identifying geographic regions with low HPV vaccination rates can help target clinical and community efforts to improve vaccination rates. Cancer Epidemiol Biomarkers Prev; 26(4); 533-40. ©2017 AACR See all the articles in this CEBP Focus section, "Geospatial Approaches to Cancer Control and Population Sciences."
      (©2017 American Association for Cancer Research.)
    • References:
      MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24. (PMID: 17380109)
      Am J Epidemiol. 2011 May 1;173(9):1059-68. (PMID: 21430193)
      Int J Epidemiol. 2001 Aug;30(4):899-900. (PMID: 11511625)
      J Infect Dis. 2007 Oct 15;196(8):1153-62. (PMID: 17955433)
      Am J Epidemiol. 2002 Sep 1;156(5):471-82. (PMID: 12196317)
      Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):595-602. (PMID: 25576528)
      Annu Rev Public Health. 2012 Apr;33:107-22. (PMID: 22429160)
      MMWR Morb Mortal Wkly Rep. 2013 Jul 26;62(29):591-5. (PMID: 23884346)
      MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):850-8. (PMID: 27561081)
      Prev Med. 2016 Aug;89:327-333. (PMID: 26930513)
      J Immigr Minor Health. 2013 Aug;15(4):732-40. (PMID: 23081659)
      Pediatrics. 2006 Nov;118(5):2135-45. (PMID: 17079588)
      JAMA Pediatr. 2014 Jan;168(1):76-82. (PMID: 24276343)
      Am J Prev Med. 2010 May;38(5):525-33. (PMID: 20409501)
      MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):784-92. (PMID: 26225476)
      MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626-9. (PMID: 20508593)
      Sci Am. 1981 Oct;245(4):54-63. (PMID: 7027437)
      Pediatr Infect Dis J. 2007 Mar;26(3):201-9. (PMID: 17484215)
      Mayo Clin Proc. 1996 Mar;71(3):266-74. (PMID: 8594285)
      Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):309-17. (PMID: 26768989)
      Am J Prev Med. 2017 Jun;52(6):742-752. (PMID: 27890518)
      Am J Epidemiol. 2010 Feb 1;171(3):357-67. (PMID: 20047978)
      BMJ Open. 2015 Aug 27;5(8):e008617. (PMID: 26316652)
    • Grant Information:
      R01 AG034676 United States AG NIA NIH HHS
    • الرقم المعرف:
      0 (Papillomavirus Vaccines)
    • الموضوع:
      Date Created: 20170216 Date Completed: 20180213 Latest Revision: 20231112
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC5405772
    • الرقم المعرف:
      10.1158/1055-9965.EPI-16-0877
    • الرقم المعرف:
      28196849